Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Biochemical and Biophysical Research Communications|January 17, 1995
Inhibition of cardiac sarcolemmal sodium-calcium exchanger by glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4-5-bisphosphateS Luciani, M Antolini, S Bova, et al.Biochimica Et Biophysica Acta|July 22, 1988
The glycosphingolipids of human prostate tissueT Shiraishi, M T Kinter, S E Mills, et al.Cell|August 10, 2000
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channelsJ Platzer, J Engel, A Schrott-Fischer, et al.The Prostate|September 6, 2001
Methylation and mutational analysis of p27(kip1) in prostate carcinomaA S Kibel, M Christopher, D A Faith, et al.Hypertension (Dallas, Tex. : 1979)|June 1, 1991
Effects of an endogenous ouabainlike compound on heart and aortaS Bova, M P Blaustein, J H Ludens, et al.Urology|June 1, 1997
Detection of intact prostate cancer cells in the blood of men with prostate cancerP O Ts'o, J Pannek, Z P Wang, et al.The Journal of Urology|August 1, 1996
Hypermethylation of chromosome 17P locus D17S5 in human prostate tissueR A Morton, J J Watkins, G S Bova, et al.Cancer Surveys|January 1, 1995
Molecular biology of prostate cancer progressionW B Isaacs, G S Bova, R A Morton, et al.Biochemical and Biophysical Research Communications|December 9, 2000
Callipeltin A, a cyclic depsipeptide inhibitor of the cardiac sodium-calcium exchanger and positive inotropic agentL Trevisi, S Bova, G Cargnelli, et al.The Prostate|May 8, 2001
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progressionE S Pizer, B R Pflug, G S Bova, et al.Pageof 11